303 related articles for article (PubMed ID: 15545177)
21. Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas--diagnostic and biologic significance.
Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
Hepatogastroenterology; 1999; 46(28):2599-605. PubMed ID: 10522048
[TBL] [Abstract][Full Text] [Related]
22. Cystic neoplasms of the pancreas with mucin-production.
Goh BK; Tan YM; Cheow PC; Chung YF; Chow PK; Wong WK; Ooi LL
Eur J Surg Oncol; 2005 Apr; 31(3):282-7. PubMed ID: 15780564
[TBL] [Abstract][Full Text] [Related]
23. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
[TBL] [Abstract][Full Text] [Related]
24. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
25. Fine-needle aspiration cytology of mucinous tumors of the pancreas.
Recine M; Kaw M; Evans DB; Krishnamurthy S
Cancer; 2004 Apr; 102(2):92-9. PubMed ID: 15098253
[TBL] [Abstract][Full Text] [Related]
26. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities.
Kawai M; Uchiyama K; Tani M; Onishi H; Kinoshita H; Ueno M; Hama T; Yamaue H
Arch Surg; 2004 Feb; 139(2):188-92. PubMed ID: 14769579
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas.
Okada T; Masuda N; Fukai Y; Shimura T; Nishida Y; Hosouchi Y; Kashiwabara K; Nakajima T; Kuwano H
Anticancer Res; 2006; 26(4B):3105-10. PubMed ID: 16886641
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
[TBL] [Abstract][Full Text] [Related]
30. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
31. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas.
Sugiyama M; Izumisato Y; Abe N; Masaki T; Mori T; Atomi Y
Br J Surg; 2003 Oct; 90(10):1244-9. PubMed ID: 14515294
[TBL] [Abstract][Full Text] [Related]
32. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
[TBL] [Abstract][Full Text] [Related]
33. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
[TBL] [Abstract][Full Text] [Related]
34. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
[TBL] [Abstract][Full Text] [Related]
35. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
[TBL] [Abstract][Full Text] [Related]
36. Fine-needle aspiration cytology of intraductal papillary-mucinous tumors: a retrospective analysis.
Layfield LJ; Cramer H
Diagn Cytopathol; 2005 Jan; 32(1):16-20. PubMed ID: 15584051
[TBL] [Abstract][Full Text] [Related]
37. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
[TBL] [Abstract][Full Text] [Related]
38. Intraductal papillary-mucinous tumors of the pancreas: presentation of eight cases.
Wurzer H; Brandstätter G; Worm HC; Wolf G
Wien Klin Wochenschr; 2001 Nov; 113(22):880-4. PubMed ID: 11762126
[TBL] [Abstract][Full Text] [Related]
39. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
40. Smallest cystic tumor, measuring 5 mm, was identified as an invasive adenocarcinoma among multiple intraductal papillary-mucinous tumors.
Takagi K; Takada T; Yasuda H; Amano H; Yoshida M; Toyota M; Wada K
Hepatogastroenterology; 2003; 50(53):1341-4. PubMed ID: 14571733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
